These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36917594)

  • 1. Immune Profiling Panel Gene Set Identifies Critically Ill Patients With Low Monocyte Human Leukocyte Antigen-DR Expression: Preliminary Results From the REAnimation Low Immune Status Marker (REALISM) Study.
    Peronnet E; Blein S; Venet F; Cerrato E; Fleurie A; Llitjos JF; Kreitmann L; Terraz G; Conti F; Gossez M; Rimmelé T; Textoris J; Lukaszewicz AC; Brengel-Pesce K; Monneret G;
    Crit Care Med; 2023 Jun; 51(6):808-816. PubMed ID: 36917594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Profiling Panel: A Proof-of-Concept Study of a New Multiplex Molecular Tool to Assess the Immune Status of Critically Ill Patients.
    Tawfik DM; Vachot L; Bocquet A; Venet F; Rimmelé T; Monneret G; Blein S; Montgomery JL; Hemmert AC; Pachot A; Moucadel V; Yugueros-Marcos J; Brengel-Pesce K; Mallet F; Textoris J
    J Infect Dis; 2020 Jul; 222(Suppl 2):S84-S95. PubMed ID: 32691839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.
    Spinetti T; Hirzel C; Fux M; Walti LN; Schober P; Stueber F; Luedi MM; Schefold JC
    Anesth Analg; 2020 Oct; 131(4):993-999. PubMed ID: 32925314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Comparison of Monocyte Human Leukocyte Antigen-D-Related (mHLA-DR) Expression Levels Between Corona Virus Disease 2019 (COVID-19) Patients and Healthy Subjects.
    Nabilah MH; Wardhani P; Aryati A; Hernaningsih Y; Semedi BP
    Acta Med Indones; 2023 Jan; 55(1):52-60. PubMed ID: 36999265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of monocyte HLA-DR expression over time with secondary infection in critically ill children: a prospective observational study.
    Hagedoorn NN; Kolukirik P; Nagtzaam NMA; Nieboer D; Verbruggen S; Joosten KF; Moll H; Driessen G; Dik WA; Vermont C
    Eur J Pediatr; 2022 Mar; 181(3):1133-1142. PubMed ID: 34755207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses-A
    Tamulyte S; Kopplin J; Brenner T; Weigand MA; Uhle F
    Front Immunol; 2019; 10():432. PubMed ID: 30915080
    [No Abstract]   [Full Text] [Related]  

  • 7. Predicting the Outcomes of Subjects With Severe Community-Acquired Pneumonia Using Monocyte Human Leukocyte Antigen-DR.
    Zhuang Y; Li W; Wang H; Peng H; Chen Y; Zhang X; Chen Y; Gao C
    Respir Care; 2015 Nov; 60(11):1635-42. PubMed ID: 26264418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma.
    Cheron A; Floccard B; Allaouchiche B; Guignant C; Poitevin F; Malcus C; Crozon J; Faure A; Guillaume C; Marcotte G; Vulliez A; Monneuse O; Monneret G
    Crit Care; 2010; 14(6):R208. PubMed ID: 21092108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis.
    Joshi I; Carney WP; Rock EP
    Front Immunol; 2023; 14():1130214. PubMed ID: 36825018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole blood no-lyse no-wash micromethod for the quantitative measurement of monocyte HLA-DR.
    Miatello J; Faivre V; Marais C; Raineau M; Payen D; Tissieres P
    Cytometry B Clin Cytom; 2024 Jan; 106(1):58-63. PubMed ID: 37702371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spinal cord injury-induced immune deficiency syndrome: results of the SCIentinel study.
    Kopp MA; Meisel C; Liebscher T; Watzlawick R; Cinelli P; Schweizerhof O; Blex C; Lübstorf T; Prilipp E; Niedeggen A; Druschel C; Schaser KD; Wanner GA; Curt A; Lindemann G; Nugeva N; Fehlings MG; Vajkoczy P; Cabraja M; Dengler J; Ertel W; Ekkernkamp A; Rehahn K; Martus P; Volk HD; Unterwalder N; Kölsch U; Brommer B; Hellmann RC; Baumgartner E; Hirt J; Geurtz LC; Saidy RRO; Prüss H; Laginha I; Failli V; Grittner U; Dirnagl U; Schwab JM
    Brain; 2023 Aug; 146(8):3500-3512. PubMed ID: 37370200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte HLA-DR level on admission predicting in-hospital mortality rate in exertional heatstroke: A 12-year retrospective study.
    Wang F; Gong F; Shi X; Yang J; Qian J; Wan L; Tong H
    Immun Inflamm Dis; 2024 Apr; 12(4):e1240. PubMed ID: 38629749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma.
    Gouel-Chéron A; Allaouchiche B; Guignant C; Davin F; Floccard B; Monneret G;
    PLoS One; 2012; 7(3):e33095. PubMed ID: 22431998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of the monocyte human leukocyte antigen-DR level in the assessment of the severity of acute pancreatitis].
    Xu Z; Ma M; Chen S; Wu T
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):221-4. PubMed ID: 29916678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock.
    Venet F; Tissot S; Debard AL; Faudot C; Crampé C; Pachot A; Ayala A; Monneret G
    Crit Care Med; 2007 Aug; 35(8):1910-7. PubMed ID: 17568330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Real-Time Polymerase Chain Reaction Measurement of HLA-DRA Gene Expression in Whole Blood Is Highly Reproducible and Shows Changes That Reflect Dynamic Shifts in Monocyte Surface HLA-DR Expression during the Course of Sepsis.
    Cajander S; Tina E; Bäckman A; Magnuson A; Strålin K; Söderquist B; Källman J
    PLoS One; 2016; 11(5):e0154690. PubMed ID: 27144640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples.
    Demaret J; Walencik A; Jacob MC; Timsit JF; Venet F; Lepape A; Monneret G
    Cytometry B Clin Cytom; 2013; 84(1):59-62. PubMed ID: 22987669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock.
    Monneret G; Lepape A; Voirin N; Bohé J; Venet F; Debard AL; Thizy H; Bienvenu J; Gueyffier F; Vanhems P
    Intensive Care Med; 2006 Aug; 32(8):1175-83. PubMed ID: 16741700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of critically ill patients cannot be defined by cutoff values of monocyte human leukocyte antigen-DR expression.
    Trimmel H; Luschin U; Köhrer K; Anzur C; Vevera D; Spittler A
    Shock; 2012 Feb; 37(2):140-4. PubMed ID: 22089188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of circulating monocyte HLA-DR expression in a large cohort of intensive care patients: relation with secondary infections.
    de Roquetaillade C; Dupuis C; Faivre V; Lukaszewicz AC; Brumpt C; Payen D
    Ann Intensive Care; 2022 May; 12(1):39. PubMed ID: 35526199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.